Search Within

Yanming Zhang

  1. "2018"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (6)
Groups
  1. Department of Pathology and Laboratory Medicine (18)
  2. Center for Hematologic Malignancies (12)
  3. Department of Medicine (10)
  4. Hematologic Malignancies, Division of (10)
  5. Adult Leukemia (9)
  6. Epidemiology and Biostatistics (5)

More Groups

People
  1. Mikhail Roshal (8)
  2. Martin Tallman (7)
  3. Wenbin Xiao (7)
  4. Maria Arcila (6)
  5. Ahmet Dogan (5)
  6. Christopher Famulare (4)

More People

Years
  1. 2018 (18)
Publications
  1. Blood (7)
  2. Modern Pathology (4)
  3. Blood Advances (2)
  4. Cold Spring Harbor Molecular Case Studies (2)
  5. Journal of Clinical Oncology (1)
  6. Leukemia (1)

More Publications

Publishers
  1. American Society of Hematology (9)
  2. Nature Research (4)
  3. Cold Spring Harbor Laboratory Press (2)
  4. Nature Publishing Group (2)
  5. American Society of Clinical Oncology (1)

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Venous thrombotic events in Philadelphia chromosome-like acute lymphoblastic leukemia
    Meeting Abstract

    Patel, A. A.; Sellers, M.; Zhang, Y.; Dinner, S. N.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Evolution of a chemosensitive core-binding factor AML into an aggressive leukemia with eosinophilic differentiation
    Journal Article

    Xiao, W.; Yabe, M.; Offin, M.; Khattar, P.; Baik, J.; Daley, R. J.; Pappacena, J. J.; Roshal, M.; Zhang, Y.; Tallman, M. S.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • PHF6 mutations are mutually exclusive to TP53 mutations, and define a distinct subgroup of secondary acute myeloid leukemia associated with a primitive stem/progenitor immunophenotype, absent complex karyotype and relatively better outcomes
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Ball, B.; Famulare, C.; Pastore, F.; Tallman, M. S.; Zhang, Y.; Arcila, M. E.; Papaemmanuil, E.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Characterization of novel subtypes in B progenitor acute lymphoblastic leukemia
    Meeting Abstract

    Gu, Z.; Churchman, M. L.; Roberts, K. G.; Moore, I.; Zhou, X.; Nakitandwe, J.; Hagiwara, K.; Pelletier, S.; Gingras, S.; Berns, H.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Minimal residual disease (MRD) at time of complete remission is commonly detected in acute myeloid leukemia (AML) patients age ≥ 60 years and significantly impacts outcome based on post-remission treatment strategies: Prospective analysis of ECOG-ACRIN (E-A) E2906 phase III trial
    Meeting Abstract

    Foran, J. M.; Sun, Z.; Paietta, E.; Racevskis, J.; Claxton, D. F.; Lazarus, H. M.; Arber, D. A.; Rowe, J. M.; Altman, J. K.; Al-Kali, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Myeloid/histiocytic neoplasms associated with germ cell tumors harbor shared genetic abnormalities indicating a clonal relationship, unique molecular pathogenesis and cellular origin
    Meeting Abstract

    Ho, C.; Zhang, Y.; Aypar, U.; Yabe, M.; Sen, F.; Arcila, M. E.; Dogan, A.; Petrova-Drus, K.
    Blood (2018)

    Fulltext@MSK | Save
  • FLT3-ITD mutations are prevalent and significantly impact outcome after intensive therapy in elderly adults with acute myeloid leukemia (AML): Analysis of the North American Intergroup E2906 phase III trial in patients age ≥ 60 years
    Meeting Abstract

    Foran, J. M.; Sun, Z.; Paietta, E.; Racevskis, J.; Claxton, D. F.; Lazarus, H. M.; Arber, D. A.; Rowe, J. M.; Godwin, J.; Zhang, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A case of KMT2A-SEPT9 fusion-associated acute megakaryoblastic leukemia
    Journal Article

    Forlenza, C. J.; Zhang, Y.; Yao, J.; Benayed, R.; Steinherz, P.; Ramaswamy, K.; Kessel, R.; Roshal, M.; Shukla, N.
    Cold Spring Harbor Molecular Case Studies (2018)

    Fulltext@MSK | Save